Vericel Corp: Form 10-K for the period ended Dec 31, 2020
Filed with the SEC on Feb 24, 2021 and accepted by EDGAR at Feb 24, 2021, 16:48 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-10-01 to 2020-12-31 | $45.2m | us-gaap:Revenues |
| Revenue | 12 months2020-01-01 to 2020-12-31 | $122.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2020-01-01 to 2020-12-31 | $40.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-10-01 to 2020-12-31 | $33.6m | us-gaap:GrossProfit |
| Gross profit | 12 months2020-01-01 to 2020-12-31 | $84.2m | us-gaap:GrossProfit |
| Research and development | 12 months2020-01-01 to 2020-12-31 | $13.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2020-01-01 to 2020-12-31 | $68.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-10-01 to 2020-12-31 | $12.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2020-01-01 to 2020-12-31 | $2.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2020-01-01 to 2020-12-31 | $13.0k | us-gaap:InterestExpense |
| Income tax | 12 months2020-01-01 to 2020-12-31 | $180.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-10-01 to 2020-12-31 | $12.2m | us-gaap:NetIncomeLoss |
| Net income | 12 months2020-01-01 to 2020-12-31 | $2.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-10-01 to 2020-12-31 | $0.25 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2020-01-01 to 2020-12-31 | $0.06 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-10-01 to 2020-12-31 | $0.27 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2020-01-01 to 2020-12-31 | $0.06 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2020-01-01 to 2020-12-31 | 47,282,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2020-01-01 to 2020-12-31 | $17.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2020-01-01 to 2020-12-31 | $2.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2020-12-31 | $33.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-12-31 | $123.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | $205.6m | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | $22.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-12-31 | $71.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-12-31 | $134.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-21-003081. Last ingested by Listed: Nov 13, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.